Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia Patients of Pakistan

NCT03651102 is registered in ClinicalTrials.gov with Blood Diseases Clinic as lead sponsor.

NCT NCT03651102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03651102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Low Dose Thalidomide in Transfusion Dependent Thalassemia Patients of Pakistan
Lead sponsor
Blood Diseases Clinic
Phase
Phase 2/3
Overall status
Completed
Start date
January 1, 2018
Completion date
March 1, 2022
Enrollment
654 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia